PTCL Clinical Trial
Official title:
A Retrospective (Non-interventional) Clinical Study on the First-line Maintenance Treatment of Peripheral T-cell Lymphoma (PTCL) With Chidamide.
The efficacy and safety of chidamide in first-line maintenance therapy for PTCL will be assessed through a retrospective case analysis.
The study design belongs to a retrospective study, collecting information on patients with PTCL who were diagnosed and treated with chidamide as maintenance therapy at our center. The collected data includes age, gender, previous treatment regimens, results of auxiliary examinations (such as blood routine, biochemistry, bone marrow cytology, pathology, flow cytometry, NGS, etc.), as well as PET-CT images. The safety and efficacy of Chidemide as first-line maintenance therapy in PTCL will be analyzed. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03900442 -
Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort
|
Phase 1 | |
| Withdrawn |
NCT02757248 -
Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL
|
Phase 1 | |
| Not yet recruiting |
NCT05238064 -
Parsaclisib in Combination With CHOP in Participants With Previously Untreated PTCL
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03240211 -
Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL
|
Phase 1 | |
| Recruiting |
NCT04747236 -
Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL
|
Phase 2 | |
| Not yet recruiting |
NCT04705090 -
A Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma
|
Phase 2 | |
| Completed |
NCT03493451 -
Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms
|
Phase 2 | |
| Recruiting |
NCT03884205 -
GDPE/CEOPE Compared With CEOPE for Newly Diagnosed Patients With PTCL
|